Activist investors boosting stakes in short seller targets Temenos, Grifols seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Grifols in talks for a partial sale of Shanghai RAAS seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
RIYADH: The Saudi Arabian pharmaceutical drugs market was estimated to be worth $10.19 billion last year and is expected to grow at an annual rate of 7.3 percent over the next six years, new data has revealed.
The optimistic forecast was partly based on the Kingdom’s plans to expand local manufacturing capabilities, according to a report by US-based research company Coherent Market Insights.
“Rapid reforms in the healthcare sector in Saudi Arabia by the government and multinational companies is expected to propel growth of the Saudi Arabia pharmaceutical drugs market,” the report said.
Throughout 2020, a number of high-profile agreements and partnerships were announced within the sector.